ArticleActa pharmacologica Sinica2023

Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma.

Lu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.